Immunologic mechanisms of alcoholic liver injury

Seminars in Liver Disease

Volumn 24, Issue 3, 2004, Pages 273-287

  Thiele, Geoffrey M ^a,b,c   Freeman, Thomas L ^b,c   Klassen, Lynell W ^b,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

^c VA Alcohol Research Center   (United States)

Author keywords

Adducts; Antibodies; Autoimmunity; Immune responses; T cells

Indexed keywords

ALCOHOL; CD4 ANTIGEN; CHEMOKINE; CYTOKINE; LIPOPOLYSACCHARIDE;

ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; AUTOIMMUNITY; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HEPATITIS C; HORMONAL REGULATION; HUMAN; HYPOTHESIS; IMMUNOMODULATION; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; T LYMPHOCYTE ACTIVATION;

AUTOANTIBODIES; AUTOIMMUNITY; HUMANS; INFLAMMATION; LIVER DISEASES, ALCOHOLIC; SELF TOLERANCE; T-LYMPHOCYTES;

EID: 4444352518     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-832940     Document Type: Review

References (151)

1. Kovacs EJ, Messingham KA. Influence of alcohol and gender on immune response. Alcohol Res Health 2002;26:257-263
2. Cook RT. Alcohol abuse, alcoholism, and damage to the immune system - a review. Alcohol Clin Exp Res 1998;22:1927-1942
3. Diaz LE, Montero A, Gonzalez-Gross M, et al. Influence of alcohol consumption on immunological status: a review. Eur J Clin Nutr 2002;56(Suppl 3):S50-S53
4. Nelson S, Kolls JK. Alcohol, host defence and society. Nat Rev Immunol 2002;2:205-209
5. Messingham KA, Faunce DE, Kovacs EJ. Alcohol, injury, and cellular immunity. Alcohol 2002;28:137-149
6. Bailey RJ, Krasner N, Eddleston AL, et al. Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease. BMJ 1976;2:727-729
7. Zetterman RK, Sorrell MF. Immunologic aspects of alcoholic liver disease. Gastroenterology 1981;81:616-624
8. Baddour N, Demetris AJ, Shah G, Tringali R, Van Thiel DH. The prevalence, rate of onset and spectrum of histologic liver disease in alcohol abusing liver allograft recipients. Gastroenterology 1992;102:A777
9. Carithers RL Jr, Herlong HF, Diehl AM, et al. Methyl-prednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989;110:685-690
10. Ramond MJ, Poynard T, Rueff B, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326:507-512
11. Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, Benjamin SB. Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med 1986;104:399-404
12. Moshage H, Casini A, Lieber CS. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology 1990;12:511-515
13. Casini A, Cunningham M, Rojkind M, Lieber CS. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 1991;13:758-765
14. Pares A, Potter JJ, Rennie L, Mezey E. Acetaldehyde activates the promoter of the mouse alpha 2(I) collagen gene. Hepatology 1994;19:498-503
15. Wands JR, Carter EA, Bucher NL, Isselbacher KJ. Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology 1979;77:528-531
16. Leevv CM. Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine (Baltimore) 1962;41:249-276
17. Gluud C, Christoffersen P, Eriksen J, Wantzin P, Knudsen BB. Influence of ethanol on development of hyperplastic nodules in alcoholic men with micronodular cirrhosis. Gastroenterology 1987;93:256-260
18. Worrall S, Thiele GM. Protein modification in ethanol toxicity. Adverse Drug React Toxicol Rev 2001;20:133-159
19. Klassen LW, Tuma D, Sorrell MF. Immune mechanisms of alcohol-induced liver disease. Hepatology 1995;22:355-357
20. Tuma DJ, Sorrel MF. The role of acetaldehyde adducts in liver injury. In: Hall P, ed. Alcoholic Liver Disease: Pathology and Pathogenesis, 2nd ed. London: Edward Arnold; 1995:89-99
21. Sorrell MF, Tuma DJ. Hypothesis: alcoholic liver injury and the covalent binding of acetaldehyde. Alcohol Clin Exp Res 1985;9:306-309
22. Tuma DJ, Newman MR, Donohue TM Jr, Sorrell MF. Covalent binding of acetaldehyde to proteins: participation of lysine residues. Alcohol Clin Exp Res 1987;11:579-584
23. Kamimura S, Gaal K, Britton RS, et al. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology 1992;16:448-453
24. Benedetti A, Comporti M. Formation reactions and toxicity of aldehydes produced in the course of lipid peroxidation in cellular membranes. Bioelectrochem Bioenerg 1987;18:187-202
25. Israel Y, Orrego H, Niemela O. Immune responses to alcohol metabolites: pathogenic and diagnostic implications. Semin Liver Dis 1988;8:81-90
26. Tuma DJ, Klassen LW. Immune responses to acetaldehyde-protein adducts: role in alcoholic liver disease. Gastroenterology 1992;103:1969-1973
27. Crossley IR, Neuberger J, Davis M, Williams R, Eddleston AL. Ethanol metabolism in the generation of new antigenic determinants on liver cells. Gut 1986;27:186-189
28. Lin RC, Smith RS, Lumeng L. Detection of a protein-acetaldehyde adduct in the liver of rats fed alcohol chronically. J Clin Invest 1988;81:615-619
29. Niemela O, Parkkila S, Yla-Herttuala S, et al. Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease. Hepatology 1995;22:1208-1214
30. Hoerner M, Behrens UJ, Worner T, Lieber CS. Humoral immune response to acetaldehyde adducts in alcoholic patients. Res Commun Chem Pathol Pharmacol 1986;54:3-12
31. Worrall S, de Jersey J, Shanley BC, Wilce PA. Ethanol induces the production of antibodies to acetaldehyde-modified epitopes in rats. Alcohol Alcohol 1989;24:217-223
32. Lin RC, Lumeng L, Shahidi S, Kelly T, Pound DC. Protein-acetaldehyde adducts in serum of alcoholic patients. Alcohol Clin Exp Res 1990;14:438-443
33. Niemela O, Juvonen T, Parkkila S. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. J Clin Invest 1991;87:1367-1374
34. Terabayashi H, Kolber MA. The generation of cytotoxic T lymphocytes against acetaldehyde-modified syngeneic cells. Alcohol Clin Exp Res 1990;14:893-899
35. Yokoyama H, Nagata S, Moriya S, et al. Hepatic fibrosis produced in guinea pigs by chronic ethanol administration and immunization with acetaldehyde adducts. Hepatology 1995;21:1438-1442
36. Worrall S, de Jersey J, Wilce PA. Liver damage in ethanol-fed rats injected with acetaldehyde modified proteins. Alcohol Clin Exp Res 1992;16:623
37. Israel Y, Hurwitz E, Niemela O, Arnon R. Monoclonal and polyclonal antibodies against acetaldehyde- containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci USA 1986;83:7923-7927
38. Worrall S, de Jersey J, Shanley BC, Wilce PA. Antibodies against acetaldehyde-modified epitopes: an elevated IgA response in alcoholics. Eur J Clin Invest 1991;21:90-95
39. Worrall S, de Jersey J, Shanley BC, Wilce PA. Detection of stable acetaldehyde-modified proteins in the livers of ethanol-fed rats. Alcohol Alcohol 1991;26:437-444
40. Niemela O, Parkkila S, Juvonen RO, et al. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. J Hepatol 2000;33:893-901
41. Klassen LW, Tuma DJ, Sorrell MF, et al. Detection of reduced acetaldehyde protein adducts using a unique monoclonal antibody. Alcohol Clin Exp Res 1994;18:164-171
42. Eriksson CJ, Atkinson N, Petersen DR, Deitrich RA. Blood and liver acetaldehyde concentrations during ethanol oxidation in C57 and DBA mice. Biochem Pharmacol 1984;33:2213-2216
43. Houglum K, Filip M, Witztum JL, Chojkier M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 1990;86:1991-1998
44. Tuma DJ, Todero SL, Barak-Bernhagen M, Sorrell MF. Effects of chronic ethanol administration on the endocytosis of cytokines by rat hepatocytes. Alcohol Clin Exp Res 1996;20:579-583
45. Xu D, Thiele GM, Beckenhauer JL, et al. Detection of circulating antibodies to malondialdehyde-acetaldehyde (MAA) adducts in ethanol-fed rats. Gastroenterology 1997;115:686-692
46. Worrall S, de Jersey J, Wilce PA. Comparison of the formation of proteins modified by direct and indirect ethanol metabolites in the liver and blood of rats fed the Lieber-DeCarli liquid diet. Alcohol Alcohol 2000;35:164-170
47. Thiele GM, Tuma DJ, Willis MS, et al. Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant. Alcohol Clin Exp Res 1998;22:1731-1739
48. Albano E, Tomasi A, Goria-Gatti L, Dianzani MU. Spin trapping of free radical species produced during the microsomal metabolism of ethanol. Chem Biol Interact 1988;65:223-234
49. Albano E, Parola M, Comoglio A, Dianzani MU. Evidence for the covalent binding of HERs to rat liver microsomal proteins. Alcohol Alcohol 1993;28:453-459
50. Thiele GM, Miller JA, Klassen LW, Tuma DJ. Long-term ethanol administration alters the degradation of acetaldehyde adducts by liver endothelial cells. Hepatology 1996;24:643-648
51. Thiele GM, Miller JA, Klassen LW, Tuma DJ. Chronic ethanol consumption impairs receptor-mediated endocytosis of formaldehyde-treated albumin by isolated rat liver endothelial cells. Hepatology 1999;29:1511-1517
52. Duryee MJ, Klassen LW, Freeman TL, et al. Chronic ethanol consumption impairs receptor-mediated endocytosis of MAA-modified albumin by liver endothelial cells. Biochem Pharmacol 2003;66:1045-1054
53. Kharbanda KK, Todero SL, Shubert KA, Sorrell MF, Tuma DJ. Malondialdehyde-acetaldehyde-protein adducts increase secretion of chemokines by rat hepatic stellate cells. Alcohol 2001;25:123-128
54. Thiele GM, Duryee MJ, Willis MS, et al. Malondialdehyde-acetaldehyde (MAA) modified proteins induce pro-inflammatory and pro-fibrotic responses by liver endothelial cells. Comp Hepatol 2004;3(Suppl 1):S25
55. Behrens UJ, Paronetto F. Studies on "liver-specific" antigens. I. Evaluation of the liver specificity of "LSP" and "LP-2". Gastroenterology 1979;77:1045-1052
56. McFarlane IG, Wojcicka BM, Williams R. Antigens of the human liver. Clin Exp Immunol 1980;40:1-7
57. Manns M, Meyer zum Buschenfelde KH, Hess G. Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease- specificity. Gut 1980;21:955-961
58. Perperas A, Tsantoulas D, Portmann B, Eddleston AL, Williams R. Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease. Gut 1981;22:149-152
59. Burt AD, Anthony RS, Hislop WS, Bouchier IA, MacSween RN. Liver membrane antibodies in alcoholic liver disease: 1. prevalence and immunoglobulin class. Gut 1982;23:221-225
60. Wiedmann KH, Bartholemew TC, Brown DJ, Thomas HC. Liver membrane antibodies detected by immunoradiometric assay in acute and chronic virus-induced and autoimmune liver disease. Hepatology 1984;4:199-204
61. Vidali M, Stewart SF, Rolla R, et al. Genetic and epigenetic factors in autoimmune eactions toward cytochrome P4502E1 in alcoholic liver disease. Hepatology 2003;37:410-419
62. Moncada C, Torres V, Varghese G, Albano E, Israel Y. Ethanol-derived immunoreactive species formed by free radical mechanisms. Mol Pharmacol 1994;46:786-791
63. Clot P, Parola M, Bellomo G, et al. Role of plasma membrane HER adducts in causing antibody-dependent cytotoxicity in hepatocytes exposed to alcohol. Hepatology. 1995;22:227A
64. Dupont I, Lucas D, Clot P, Menez C, Albano E. Cytochrome P4502E1 inducibility and HER formation among alcoholics. J Hepatol 1998;28:564-571
65. Clot P, Parola M, Bellomo G, et al. Plasma membrane HER adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol. Gastroenterology 1997;113:265-276
66. Shimada S, Yamauchi M, Takamatsu M, et al. Experimental studies on the relationship between immune responses and liver damage induced by ethanol after immunization with homologous acetaldehyde adducts. Alcohol Clin Exp Res 2002;26(Suppl 8):86S-90S
67. Klassen LW, Thiele GM. Immune reactivity to proteins biotransformed by alcohol metabolites. Alcohol Clin Exp Res 1998;22(Suppl 5):204S-207S
68. Skog OJ. The wetness of drinking cultures: a key variable in epidemiology of alcoholic liver cirrhosis. Acta Med Scand Suppl 1985;703:157-184
69. Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann N Y Acad Sci 1975;252:85-105
70. Lelbach WK. Epidemiology of alcoholic liver disease. Prog Liver Dis 1976;5:494-515
71. Campbell RD, Milner CM. MHC genes in autoimmunity. Curr Opin Immunol 1993;5:887-893
72. Morgan MY, Ross MG, Ng CM, et al. HLA-B8, immunoglobulins, and antibody responses in alcohol-related liver disease. J Clin Pathol 1980;33:488-492
73. Melendez M, Vargas-Tank L, Fuentes C, et al. Distribution of HLA histocompatibility antigens, ABO blood groups and Rh antigens in alcoholic liver disease. Gut 1979;20:288-290
74. Bell H, Nordhagen R. Association between HLA-BW40 and alcoholic liver disease with cirrhosis. BMJ 1978;1:822
75. Bell H, Nordhagen R. HLA antigens in alcoholics, with special reference to alcoholic cirrhosis. Scand J Gastroenterol 1980;15:453-456
76. Scott BB, Rajah SM, Losowsky MS. Histocompatibility antigens in chronic liver disease. Gastroenterology 1977;72:122-125
77. Simon M, Bourel M, Genetet B, et al. Idiopathic hemochromatosis and iron overload in alcoholic liver disease: differentiation by HLA phenotype. Gastroenterology 1977;73:655-658
78. Wilkinson P, Santamaria JN, Rankin JG. Epidemiology of alcoholic cirrhosis. Australas Ann Med 1969;18:222-226
79. Krasner N, Davis M, Portmann B, Williams R. Changing pattern of alcoholic liver disease in Great Britain: relation to sex and signs of autoimmunity. BMJ 1977;1:1497-1500
80. Morgan MY, Sherlock S. Sex-related differences among 100 patients with alcoholic liver disease. BMJ 1977;1:939-941
81. Tuyns AJ, Pequignot G. Greater risk of ascitic cirrhosis in females in relation to alcohol consumption. Int J Epidemiol 1984;13:53-57
82. Saunders JB, Wodak AD, Haines A, et al. Accelerated development of alcoholic cirrhosis in patients with HLA-B8. Lancet 1982;1:1381-1384
83. Prytz H, Skinhoj P. Morbidity, mortality, and incidence of cirrhosis in Denmark 1976-1978. Scand J Gastroenterol 1981;16:839-844
84. Bounds W, Betzing KW, Stewart RM, Holcombe RF. Social drinking and the immune response: impairment of lymphokine-activated killer activity. Am J Med Sci 1994;307:391-395
85. Chiappelli F, Kung M, Lee P, et al. Alcohol modulation of human normal T-cell activation, maturation, and migration. Alcohol Clin Exp Res 1995;19:539-544
86. Degos F, Duhamel G, Brechot C, et al. Hepatitis B vaccination in chronic alcoholics. J Hepatol 1986;2:402-409
87. Watson RR, Borgs P, Witte M, et al. Alcohol, immunomodulation, and disease. Alcohol Alcohol 1994;29:131-139
88. Peterson JD, Vasquez K, Waltenbaugh C. Interleukin-12 therapy restores cell-mediated immunity in ethanol-consuming mice. Alcohol Clin Exp Res 1998;22:245-251
89. Uchimura Y, Sata M, Kage M, Abe H, Tanikawa K. A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver 1995;15:300-306
90. Tamai T, Seki T, Shiro T, et al. Effects of alcohol consumption on histological changes in chronic hepatitis C: a clinicopathological study. Alcohol Clin Exp Res 2000;24(Suppl 4):106S-111S
91. Mufti SI, Prabhala R, Moriguchi S, Sipes IG, Watson RR. Functional and numerical alterations induced by ethanol in the cellular immune system. Immunopharmacology 1988;15:85-93
92. Szabo G, Mandrekar P, Dolganiuc A, Catalano D, Kodys K. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels. Alcohol Clin Exp Res 2001;25:1766-1772
93. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997;25:449-458
94. Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991;12:162-169
95. Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 1987;4:8-14
96. Stern M, Carter EA, Walker WA. Food proteins and gut mucosal barrier. IV. Effects of acute and chronic ethanol administration on handling and uptake of bovine serum albumin by rat small intestine. Dig Dis Sci 1986;31:1242-1248
97. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 2000;32:742-747
98. Urbaschek R, McCuskey RS, Rudi V, et al. Endotoxin, endotoxin- neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. Alcohol Clin Exp Res 2001;25:261-268
99. Thurman RG. II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 1998;275:G605-G611
100. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 1994;20:453-460
101. Jarvelainen HA, Fang C, Ingelman-Sundberg M, et al. Kupffer cell inactivation alleviates ethanol-induced steatosis and CYP2E1 induction but not inflammatory responses in rat liver. J Hepatol 2000;32:900-910
102. Mezey E. Alcoholic liver disease. Prog Liver Dis 1982;7:555-572
103. French SW, Burbige EJ. Alcoholic hepatitis: clinical, morphologic, pathogenic, and therapeutic aspects. Prog Liver Dis 1979;6:557-579
104. Bhagwandeen BS, Apte M, Manwarring L, Dickeson J. Endotoxin induced hepatic necrosis in rats on an alcohol diet. J Pathol 1987;152:47-53
105. Arai M, Nakano S, Okuno F, et al. Endotoxin-induced hypercoagulability: a possible aggravating factor of alcoholic liver disease. Hepatology 1989;9:846-851
106. Honchel R, Ray MB, Marsano L, et al. Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcohol Clin Exp Res 1992;16:665-669
107. Hoffmann R, Grewe M, Estler HC, Schulze-Specking A, Decker K. Regulation of tumor necrosis factor-alpha-mRNA synthesis and distribution of tumor necrosis factor-alpha-mRNA synthesizing cells in rat liver during experimental endotoxemia. J Hepatol 1994;20:122-128
108. Thiele GM, Klassen LW, Miller JA, Hill GE, Tuma DJ. Binding of aldehyde-modified proteins to liver endothelial cells changes the adhesion molecule and TNF-alpha Expression. J Allergy Clin Immunol 1997;99:S195
109. Nanji AA, Zhao S, Sadrzadeh SM, Waxman DJ. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 1994;19:1483-1487
110. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1998;9:349-351
111. Felver ME, Mezey E, McGuire M, et al. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990;14:255-259
112. Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990;112:917-920
113. Shiratori Y, Takada H, Hikiba Y, et al. Production of chemotactic factor, interleukin-8, from hepatocytes exposed to ethanol. Hepatology 1993;18:1477-1482
114. Van Zee KJ, Fischer E, Hawes AS, et al. Effects of intravenous IL-8 administration in nonhuman primates. J Immunol 1992;148:1746-1752
115. Hill DB, Marsano LS, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 1993;18:576-580
116. Sheron N, Bird G, Koskinas J, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993;18:41-46
117. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology, 1991;13:267-276
118. McClain CJ, Cohen DA, Dinarello CA, et al. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sci 1986;39:1479-1485
119. Deviere J, Content J, Denys C, et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990;11:628-634
120. Kishimoto T. The biology of interleukin-6. Blood 1989;74:1-10
121. Deviere J, Content J, Denys C, et al. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin Exp Immunol 1989;77:221-225
122. Hill DB, Marsano L, Cohen D, et al. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 1992;119:547-552
123. McClain C, Hill D, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis 1993;13:170-182
124. Ulich TR, Guo K, del Castillo J. Endotoxin-induced cytokine gene expression in vivo. I. Expression of tumor necrosis factor mRNA in visceral organs under physiologic conditions and during endotoxemia. Am J Pathol 1989;134:11-14
125. Peristeris P, Clark BD, Gatti S, et al. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol 1992;140:390-399
126. Deaciuc IV, Alappat JM, D'Souza NB. Effect of acute and chronic alcohol administration to rats on the expression of interleukin-6 cell-surface receptors of hepatic parenchymal and nonparenchymal cells. Alcohol Clin Exp Res 1994;18:1207-1214
127. Mills PR, Shenkin A, Anthony RS, et al. Assessment of nutritional status and in vivo immune responses in alcoholic liver disease. Am J Clin Nutr 1983;38:849-859
128. Calvey H, Davis M, Williams R. Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis. J Hepatol 1985;1:141-151
129. Thestrup-Pedersen K, Ladefoged K, Andersen P. Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease. Clin Exp Immunol 1976;24:1-8
130. Young GP, Dudley FJ, Van Der Weyden MB. Suppressive effect of alcoholic liver disease sera on lymphocyte transformation. Gut 1979;20:833-839
131. Pelletier G, Segond P, Attali P, Briantais MJ, Etienne JP. Phenotype study of blood T lymphocytes in alcoholic hepatopathies. Gastroenterol Clin Biol 1984;8:911-924
132. Perrin D, Bignon JD, Beaujard E, Cheneau ML. Populations of circulating T lymphocytes in patients with alcoholic cirrhosis. Gastroenterol Clin Biol 1984;8:907-910
133. Couzigou P, Vincendeau P, Fleury B, et al. Changes in circulating lymphocyte subsets in alcoholic hepatopathies. Respective role of alcohol, hepatocellular insufficiency and malnutrition. Gastroenterol Clin Biol 1984;8:915-919
134. Watson RR, Jackson JC, Hartmann B, et al. Cellular immune functions, endorphins, and alcohol consumption in males. Alcohol Clin Exp Res 1985;9:248-254
135. Si L, Whiteside TL, Schade RR, Van Thiel D. Lymphocyte subsets studied with monoclonal antibodies in liver tissues of patients with alcoholic liver disease. Alcohol Clin Exp Res 1983;7:431-435
136. Muller C, Wolf H, Gottlicher J, Eibl MM. Helper-inducer and suppressor-inducer lymphocyte subsets in alcoholic cirrhosis. Scand J Gastroenterol 1991;26:295-301
137. Van Epps E, Husby G, Williams RC Jr, Strickland RG. Liver disease - a prominent cause of serum IgE elevation. Clin Exp Immunol 1976;23:444-450
138. Iturriaga H, Pereda T, Estevez A, Ugarte G. Serum immunoglobulin A changes in alcoholic patients. Ann Clin Res 1977;9:39-43
139. Sorrell MF. Leevy CM. Lymphocyte transformation and alcoholic liver injury. Gastroenterology 1972;63:1020-1025
140. Zetterman RK, Leevy CM. Immunologic reactivity and alcoholic liver disease. Bull N Y Acad Med 1975;51:533-544
141. Zetterman RK, Luisada-Opper A. LEEVY CM. Alcoholic hepatitis. Cell-mediated immunological response to alcoholic hyalin. Gastroenterology 1976;70:382-384
142. Johnson RD, Williams R. Immune responses in alcoholic liver disease. Alcohol Clin Exp Res 1986;10:471-486
143. Izumi N, Hasumura Y, Takeuchi J. Lymphocyte cytotoxicity for autologous human hepatocytes in alcoholic liver disease. Clin Exp Immunol 1983;54:219-224
144. Poralla T, Hutteroth TH, Meyer zum Buschenfelde KH. Cellular cytotoxicity against autologous hepatocytes in alcoholic liver disease. Liver 1984;4:117-121
145. Anthony RS, Farquharson M, MacSween RN. Liver membrane antibodies in alcoholic liver disease. II. Antibodies to ethanol-altered hepatocytes. J Clin Pathol 1983;36:1302-1308
146. Neuberger J, Crossley IR, Saunders JB, et al. Antibodies to alcohol altered liver cell determinants in patients with alcoholic liver disease. Gut 1984;25:300-304
147. Izumi N, Sato C, Hasumura Y, Takeuchi J. Serum antibodies against alcohol-treated rabbit hepatocytes in patients with alcoholic liver disease. Clin Exp Immunol 1985;61:585-952
148. Niemela O, Parkkila S, Yla-Herttuala S, et al. Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation. Lab Invest 1994;70:537-546
149. Tuma DJ, Thiele GM, Xu D, Klassen LW, Sorrell MF. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology 1996;23:872-880
150. Albano E, Tomasi A, Persson JO, et al. Role of ethanol-inducible cytochrome P450 (P450IIE1) in catalysing the free radical activation of aliphatic alcohols. Biochem Pharmacol 1991;41:1895-1902
151. Clot P, Bellomo G, Tabone M, Arico S, Albano E. Detection of antibodies against proteins modified by hydroxyethyl free radicals in patients with alcoholic cirrhosis. Gastroenterology 1995;108:201-207